Abstract

Ectopic ACTH syndrome (EAS) arising years after the diagnosis of a neuroendocrine tumor (NET) is exceedingly rare. We describe a case of EAS occurring five years after the diagnosis of a metastatic lung NET in a 61-year-old woman. She presented with severe hypokalemia but was not overtly Cushingoid on exam. Serum cortisol was 61mcg/dL after an overnight 1mg dexamethasone suppression test (<1.8mcg/dL) and urinary free cortisol was 7544 mcg/24h (<45mcg/24h), establishing the diagnosis of Cushing's syndrome. Plasma levels of peptides which have been associated with EAS, Agouti-related peptide (AgRP) and the ACTH precursors POMC (31-kDa) and pro-ACTH (22-kDa), were elevated. Metyrapone was initiated, but hypercortisolism persisted and the patient succumbed to pneumonia shortly after presentation. Retrospective examination of biopsy tissues showed rare ACTH immunoreactivity at the time of initial diagnosis, followed by staining in a greater proportion of cells as the disease progressed, consistent with EAS arising years after the diagnosis of NET. Given the increase in mortality associated with EAS, this unusual case highlights the importance of early detection and raises the possibility that early immunohistochemical stains for ACTH and measurements of ACTH precursors may facilitate the identification of NETs at high risk for EAS.

Highlights

  • Neuroendocrine tumors (NETs) arise from cells that have the ability to synthesize and secrete various peptides and amines, some of which may be metabolically active and give rise to distinct paraneoplastic syndromes

  • Lung NETs have an annual incidence of 0.2-2.0 per 100,000 and 1% of these cases are complicated by ectopic ACTH syndrome (EAS), a rare condition characterized by tumoral ACTH production, hypercortisolism, and increased mortality [1, 2]

  • While EAS is classically associated with small-cell lung carcinomas and carcinoids, it can be a paraneoplastic complication of neuroendocrine carcinoma (NEC), an aggressive form of NET [3]

Read more

Summary

Introduction

Neuroendocrine tumors (NETs) arise from cells that have the ability to synthesize and secrete various peptides and amines, some of which may be metabolically active and give rise to distinct paraneoplastic syndromes. Lung NETs have an annual incidence of 0.2-2.0 per 100,000 and 1% of these cases are complicated by ectopic ACTH syndrome (EAS), a rare condition characterized by tumoral ACTH production, hypercortisolism, and increased mortality [1, 2]. While EAS is classically associated with small-cell lung carcinomas and carcinoids, it can be a paraneoplastic complication of neuroendocrine carcinoma (NEC), an aggressive form of NET [3]. We describe a rare case of a lung neuroendocrine carcinoma complicated by EAS five years after the tumor diagnosis.

Case Presentation
Findings
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.